Role of the mitogen-activated protein kinases in the expression of the kinin B1 receptors induced by tissue injury

Journal of Immunology

Volumn 160, Issue 3, 1998, Pages 1419-1426

  Larrivée, Jean François ^a   Bachvarov, Dimcho R ^a   Houle, François ^a   Landry, Jacques ^a   Huot, Jacques ^a   Marceau, François ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ B1 RECEPTOR; BRADYKININ DERIVATIVE; BRADYKININ[1-8]; CYTOKINE; KALLIDIN; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL TISSUE; AORTA MEDIA; ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; INFLAMMATION; KALLIKREIN KININ SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RABBIT; RECEPTOR UPREGULATION; SMOOTH MUSCLE FIBER; TISSUE INJURY;

ANIMALS; AORTA, THORACIC; BRADYKININ; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELLS, CULTURED; FEMALE; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; PROTEIN SYNTHESIS INHIBITORS; RABBITS; RECEPTOR, BRADYKININ B1; RECEPTORS, BRADYKININ;

EID: 0031940497     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Menke, J. G., J. A. Borkowski, K. K. Bierilo, T. MacNeil, A. W. Derrick, K. A. Schneck, R. W. Ransom, C. D. Strader, D. L. Linemeyer, and J. F. Hess. 1994. Expression cloning of a human B, bradykinin receptor. J. Biol. Chem. 269:21583.
2. Stewart, J. M. 1995. Bradykinin antagonists: development and applications. Biopolymers 37:143.
3. Hall, J. M. 1992. Bradykinin receptors: pharmacological properties and biological roles. Pharmacol. Ther. 56:131.
4. 1 receptors: a review. Immunopharmacology 30:1.
5. 9-bradykinin in human coronary arteries. Br. J. Pharmacol. 116:3083.
6. Zuzack, J. S., M. R. Burkard, D. Cuadrado, R. A. Greer, W. M. Selig, and E. T. Whalley. 1996. Evidence of a bradykinin B1 receptor in human ileum: pharmacological comparison to the rabbit aorta B1 receptor. J. Pharmacol. Exp. Ther. 277:1337.
7. 2 receptor mechanisms in cytokine-induced mechanical hyperalgesia in the rat. Br. J. Pharmacol. 113:63.
8. Sufka, K. J., and J. T. Roach. 1996. Stimulus properties and antinociceptive effects of selective bradykinin B1 and B2 receptor antagonists in the rat. Pain 66:99.
9. 1 receptors in the polymorphonuclear leukocyte accumulation induced by IL-1β in vivo in the mouse. J. Immunol. 156:269.
10. 9-bradykinin in vitro and in vivo. Br. J. Pharmacol. 92:257.
11. 9-bradykinin in young Brown/Norway rats pretreated with endotoxin. Eur. J. Pharmacol. 274:225.
12. 9-bradykinin increases during E. coli septicemia in the pig. Adv. Exp. Med. Biol. 247:B:389.
13. 2 production. Br. J. Pharmacol. 113:389.
14. 1 receptor: an inducible G protein coupled receptor. Can. J. Physiol. Pharmacol. 75:725.
15. 1 receptor gene for kinins (BDKRB1). Genomics 33:374.
16. 9-bradykinin: possible role of interleukin-1. Br. J. Pharmacol. 103:1057.
17. 9-bradykinin. Br. J. Pharmacol. 93:969.
18. 1 receptors for kinins. Immunopharmacology 29:141.
19. 1 receptors in rabbit aorta smooth muscle cells in culture. Eur. J. Pharmacol. 266:277.
20. Levesque, L., J.-F. Larrivée, D. R. Bachvarov, F. Rioux, G. Drapeau, and F. Marceau, F. 1995. Regulation of kinin-induced contraction and DNA synthesis by inflammatory cytokines in the smooth muscle of the rabbit aorta. Br. J. Pharmacol. 116:1673.
21. Rueff, A., A. J. L. R. Dawson, and L. M. Mendell. 1996. Characteristics of nerve growth factor induced hyperalgesia in adult rats: dependence on enhanced bradykinin-1 receptor activity but not neurokinin-1 receptor activation. Pain 66:359.
22. 9-bradykinin or of α-thrombin in rabbit aortic rings. Br. J. Pharmacol. 105:959.
23. Petitclerc, E., S. Abel, D. deBlois, P. E. Poubelle, and F. Marceau. 1992. Effect of interleukin-1 receptor antagonist on three types of responses to interleukin-1 in rabbit isolated blood vessels. J. Cardiovasc. Pharmacol. 19:821.
24. Rioux, F., E. Petitclerc, R. Audet, G. Drapeau, R. M. Fielding, and F. Marceau. 1994. Recombinant human hemoglobin inhibits both constitutive and cytokine-induced nitric oxide-mediated relaxation of rabbit isolated aortic rings. J. Cardiovasc. Pharmacol. 24:229.
25. Huot, J., F. Houle, F. Marceau, and J. Landry. 1997. Oxidative stress-induced actin reorganization mediated by the p38 mitogen-activated protein kinase/heat shock protein 27 pathway in vascular endothelial cells. Circ. Res. 80:383.
26. Dérijard, B., J. Raingeaud, T. W. Barret, I. H. Wu, J. Han, R. J. Ulevitch, and R. J. Davis. 1995. Independent human MAP kinase signal transduction pathways defined by MEK and MKK isoforms. Science 267:682.
27. Zhou, M., H. Lambert, and J. Landry. 1993. Transient activation of a distinct serine protein kinase is responsible for HSP27 phosphorylation in mitogen-stimulated and heat shocked cells. J. Biol. Chem. 268:35.
28. Kyriakis, J. M., P. Banerjee, E. Nikolakaki, T. Dai, E. A. Rubie, M. F. Ahmad, J. Avruch, and J. R. Woodgett. 1994. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369:156.
29. 1 receptors and development of a cellular model for the investigation of these receptors. Br. J. Pharmacol. 109:1254.
30. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
31. 1 receptor. Biochim. Biophys. Acta 1264:223.
32. Cuenda, A., J. Rouse, Y. N. Doza, R. Meier, P. Cohen, T. F. Gallagher, P. R. Young, and J. C. Lee. 1995. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364:229.
33. Dudley, D. T., L. Pang, S. J. Decker, A. J. Bridges, and A. R. Saltiel. 1995. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA 92:7686.
34. Akiyama, T., J. Ishida, S. Nakagawa, H. Ogawara, S. I. Watanabe, N. Itoh, M. Shibuya, and Y. Fukami. 1987. Genistein, a specific inhibitor of tyrosine specific protein kinases. J. Biol. Chem. 262:5592.
35. Huot, J., H. Lambert, J. N. Lavoie, A. Guimond, F. Houle, and J. Landry. 1995. Characterization of 45-kDa/54-kDa HSP27 kinase, a stress-sensitive kinase which may activate the phosphorylation-dependent function of mammalian 27-kDa heat-shock protein HPS27. Eur. J. Biochem. 227:416.
36. 9]-bradykinin in low-renin essential hypertension before and after treatment with enalapril (MK 421). J. Lab. Clin. Med. 102:714.
37. 9-bradykinin using a chemiluminescence enzyme immunoassay: application to its kinetic during plasma activation. J. Immunol. Methods 180:247.
38. Proud, D., C. R. Baumgarten, R. M. Nacleiro, and P. E. Ward. 1987. Kinin metabolism in human nasal secretions during experimentally induced allergic rhinitis. J. Immunol. 138:428.
39. 9-bradykinin, a metabolically protected agonist of B1 receptor for kinins, in the anesthetized rabbit pretreated with a sublethal dose of bacterial lipopolysaccharide. J. Pharmacol. Exp. Ther. 280:6.
40. Regoli, D., J. Barabé, and W. P. Park. 1977. Receptors for bradykinin in rabbit aortae. Can. J. Physiol. Pharmacol. 55:855.
41. 9-bradykinin in vivo and in vitro. Immunopharmacology 17:187.
42. Lee, J. C., J. T. Laydon, P. C. McConnell, T. F. Gallagher, S. Kumar, D. Green, D. McNulty, M. J. Blumenthal, J. R. Heys, S. W. Landvatter, J. E. Strickler, M. M. McLaughlin, I. Siemens, S. Fisher, G. P. Livi, J. R. White, J. L. Adams, and P. R. Young. 1994. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739.
43. Wang, X. Z., and D. Ron. 1996. Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP kinase. Science 272:1347.
44. Badger, A. M., J. N. Bradbeer, B. Votta, J. C. Lee, J. L. Adams, and D. E. Griswold. 1996. Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. J. Pharmacol. Exp. Ther. 279:1453.
45. 1 receptors in the maintenance of intra-articular plasma extravasation in chronic antigen-induced arthritis. Br. J. Pharmacol. 113:940.